Something felt wrong during one of Morhaf Al Achkar’s regular runs on the treadmill in late 2016. He started gasping for breath.
Soon after he was diagnosed with a dedifferentiated liposarcoma, C. Norman Coleman reached out to The Cancer Letter and the Cancer History Project to initiate a series of interviews about his life and career.
As a new deputy director at UPMC Hillman Cancer Center, Monica Baskin has assumed a level of responsibility that is unusual, if not unprecedented, for a population scientist at an NCI-designated cancer center.
In the late 1980s, R. J. Reynolds Tobacco Company made plans to market a new brand of menthol cigarette, Uptown.
What drew Jim Allison to T cells, Hagop Kantarjian to leukemia, or Betty Ford and Nancy Reagan to breast cancer advocacy?
Mary Lasker was surprised when, in 1964, President Lyndon B. Johnson called her at home and asked whether she would accept the job of U.S. ambassador to Finland.
When John Laszlo joined the Acute Leukemia Service at NCI in 1956, the field of oncology was nascent—and the cure for childhood leukemia seemed beyond reach.
Leukemia was mostly a fatal disease when Hagop Kantarjian, a medical student at the American University of Lebanon in Beirut, first came to MD Anderson in 1978.
Jed Manocherian wants your attention—but not for himself.
Soon after real estate developer and investor Jed Manocherian started a non-profit that lobbies for biomedical research, he heard about the outsized role Mary Lasker played in shaping government-funded biomedical research in the U.S.
